Mosaic Immunoengineerin Valuation
| CPMV Stock | USD 0.99 0.01 1.02% |
Today, the firm appears to be overvalued. Mosaic Immunoengineering secures a last-minute Real Value of $0.72 per share. The latest price of the firm is $0.99. Our model forecasts the value of Mosaic Immunoengineering from analyzing the firm fundamentals such as Price To Book of 9.33 X, return on asset of -4.2, and Shares Outstanding of 7.24 M as well as examining its technical indicators and probability of bankruptcy. . In general, most investors recommend buying undervalued stocks and disposing overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Mosaic Immunoengineerin's price fluctuation is out of control at this time. Calculation of the real value of Mosaic Immunoengineering is based on 3 months time horizon. Increasing Mosaic Immunoengineerin's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Mosaic otc stock is determined by what a typical buyer is willing to pay for full or partial control of Mosaic Immunoengineering. Since Mosaic Immunoengineerin is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Mosaic OTC Stock. However, Mosaic Immunoengineerin's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.99 | Real 0.72 | Hype 0.99 | Naive 0.93 |
The intrinsic value of Mosaic Immunoengineerin's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Mosaic Immunoengineerin's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Mosaic Immunoengineering helps investors to forecast how Mosaic otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Mosaic Immunoengineerin more accurately as focusing exclusively on Mosaic Immunoengineerin's fundamentals will not take into account other important factors: Mosaic Immunoengineerin Total Value Analysis
Mosaic Immunoengineering is currently expected to have valuation of 10.22 M with market capitalization of 6.01 M, debt of 735.15 K, and cash on hands of 205.99 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Mosaic Immunoengineerin fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
10.22 M | 6.01 M | 735.15 K | 205.99 K |
Mosaic Immunoengineerin Asset Utilization
One of the ways to look at asset utilization of Mosaic is to check how much profit was generated for every dollar of assets it reports. Mosaic Immunoengineering secures a negative usage of assets of -4.2 %, losing $0.042 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of Mosaic Immunoengineering shows how discouraging it operates for each dollar spent on its assets.Mosaic Immunoengineerin Ownership Allocation
Mosaic Immunoengineering secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 88.73 % of Mosaic Immunoengineering outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event.Mosaic Immunoengineerin Profitability Analysis
Net Loss for the year was (3.68 M) with profit before overhead, payroll, taxes, and interest of 0.About Mosaic Immunoengineerin Valuation
Our relative valuation model uses a comparative analysis of Mosaic Immunoengineerin. We calculate exposure to Mosaic Immunoengineerin's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Mosaic Immunoengineerin's related companies.Mosaic ImmunoEngineering Inc., a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. The company was founded in 2020 and is based in Novato, California. Mosaic Immunoengineerin operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.
8 Steps to conduct Mosaic Immunoengineerin's Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Mosaic Immunoengineerin's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Mosaic Immunoengineerin's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Mosaic Immunoengineerin's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Mosaic Immunoengineerin's revenue streams: Identify Mosaic Immunoengineerin's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Mosaic Immunoengineerin's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Mosaic Immunoengineerin's growth potential: Evaluate Mosaic Immunoengineerin's management, business model, and growth potential.
- Determine Mosaic Immunoengineerin's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Mosaic Immunoengineerin's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Mosaic Immunoengineerin Growth Indicators
Investing in growth stocks can be very risky. If the company such as Mosaic Immunoengineerin does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 7.2 M | |
| Retained Earnings | -4.5 M |
Additional Tools for Mosaic OTC Stock Analysis
When running Mosaic Immunoengineerin's price analysis, check to measure Mosaic Immunoengineerin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mosaic Immunoengineerin is operating at the current time. Most of Mosaic Immunoengineerin's value examination focuses on studying past and present price action to predict the probability of Mosaic Immunoengineerin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mosaic Immunoengineerin's price. Additionally, you may evaluate how the addition of Mosaic Immunoengineerin to your portfolios can decrease your overall portfolio volatility.